Exagen Inc.XGNNASDAQ
Loading
Price to Sales HistoryNormalizing
Percentile Rank75
3Y CAGR+29.8%
5Y CAGR-13.1%
Studio
Year-over-Year Change

Price-to-sales ratio

3Y CAGR
+29.8%/yr
vs +123.5%/yr prior
5Y CAGR
-13.1%/yr
Recent acceleration
Acceleration
-93.6pp
Decelerating
Percentile
P75
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive growthNormalizing
PeriodValueYoY Change
20251.97+46.8%
20241.34+100.3%
20230.67-25.6%
20220.90-76.6%
20213.85-3.3%
20203.98-49.6%
20197.90+21791.5%
20180.04-17.4%
20170.04-32.8%
20150.07-